Pathology and molecular biology of lung cancer

E. Brambilla (Grenoble, France)

Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Session: PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Session type: Postgraduate Course
Number: 87
Disease area: Thoracic oncology

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Brambilla (Grenoble, France). Pathology and molecular biology of lung cancer. Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009



The biology of lung cancer
Source: Eur Respir Mon; 2009: 44: 88–105
Year: 2009

New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002



High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009



Latest treatable molecular alterations in lung cancer
Source: International Congress 2017 – A novel approach to lung cancer
Year: 2017


Molecular pathology and precision medicine for lung cancer
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017


The role of molecular pathology in diagnosis and treatment of lung cancer
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007



Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005

The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013


The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



Development of an invasive 3D lung tumor model for oncological research
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006

Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010

Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016